期刊
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY
卷 5, 期 1, 页码 66-80出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187221311794474900
关键词
Multiple sclerosis; experimental autoimmune encephalomyelitis; fingolimod; FTY720; cladribine; triptolide; laquinimod; teriflunomide; fumaric acid
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system and the most common cause of neurological disability in young adults, along with a considerable clinical and pathological heterogeneity. Since, current therapies appear to be modest in the magnitude of their treatment effects, particularly in the progressive phase of this disease, thus novel promising therapeutic strategies might open a light horizon in approaching to an efficient treatment in MS. In this review, we will discuss about relevant patents and novel designed immunosuppressive and anti-inflammatory oral drugs promising for treatment of multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据